Renal cell carcinoma is the most common type of kidney cancer, comprising more than 90 percent of all kidney cancers.
Renal cell carcinoma is the most common type of kidney cancer, comprising more than 90 percent of all kidney cancers. Determining the type of RCC based on genetics and histology helps determine the best treatment and predicts survival. Recent studies involving DNA microarrays show genetic profile expressions can be used to classify renal cell carcinomas more appropriately than histology. The most common subtypes of RCC include the following:
>
Clear-cell RCC is the most common type of RCC, affecting nearly 80 percent of patients. Characterized by clear or pale cells, clear-cell RCC usually occurs in patients age 50 to 70. A mutation in the von Hippel-Lindau gene is responsible for many RCC cases, and is usually the culprit in patients under age 60.
>
Papillary RCC comprises about 10 to 15 percent of all RCC cases and can occur in hereditary or sporadic forms. Sporadic (non-hereditary) papillary RCCs have a five-year survival rate of almost 90 percent. While many papillary tumors carry a good prognosis, a certain subtype characterized by large tumor size, decreased cytokeratin 7, and an increase in an enzyme called topoisomerase II-alpha is particularly aggressive. Often involving both kidneys, papillary RCC sometimes is caused by the loss or excess of specific chromosomes. Papillary RCC occurs more often in African-Americans and is five times more likely to strike men than women.
>
Chromophobe RCC is very rare, occurring in only 5 percent of RCC cases. Tumors are composed of large clear cells. Cases of hereditary chromophobe RCC, called Birt Hogg Dubé syndrome, are caused by a defective gene thought be involved in tumor suppression. This type of RCC often only requires surgery because the cancer rarely metastasizes.
>
Renal oncocytoma is uncommon and rarely deadly. This benign tumor can grow and invade local structures, but does not spread to other parts of the body. Typically treated by surgery, it appears to be caused by the loss of certain chromosomes.
Other types of RCC include collecting duct carcinoma, renal medullary carcinoma, and sarcomatoid RCC, all of which are extremely rare.
Welireg Made a von Hippel-Lindau Survivor Feel Like a 'Medical Miracle'
December 15th 2022When Sean Korbitz was a 20-year-old college student, his life trajectory changed with a rare cancer diagnosis, resulting in the removal of 40 tumors; fifteen years later, a new drug made him feel like a “medical miracle.”
Listen
Zanzalintinib Is Promising in Clear-Cell Advanced Renal Cell Carcinoma
November 14th 2023Patients with advanced clear cell renal cell carcinoma treated with zanzalintinib had experienced promising antitumor activity with manageable toxicity regardless of prior treatment with cabozantinib.
Read More
Genetic Mutations May Explain Heart Events in Some Patients With Kidney Cancer
November 13th 2023Although research has delved into the potential link between clonal hematopoiesis and heart-related events such as heart attacks and strokes in patients with kidney cancer, more research is needed to further understand this association.
Read More